SynthesisBMJ (Clinical research ed.)2022

Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials.

Liyun He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.